Related Experiment Video
Updated: May 9, 2026

In Vivo, Percutaneous, Needle Based, Optical Coherence Tomography of Renal Masses
Published on: March 30, 2015
A clear picture of renal cell carcinoma
Abstract:
Two recent studies describe the largest molecular profiling analyses to date of clear-cell renal cell carcinoma (ccRCC) and report remarkably similar findings. The recurrent pathway alterations identified in these studies open new avenues for therapeutic advances in this chemotherapy- and radiation-resistant disease.
Insights
Two large studies reveal similar molecular profiles in clear-cell renal cell carcinoma (ccRCC). These findings offer new therapeutic strategies for this treatment-resistant kidney cancer.
Area of Science:
- Oncology
- Genomics
- Molecular Biology
Background:
- Clear-cell renal cell carcinoma (ccRCC) is a significant subtype of kidney cancer.
- Current treatments for ccRCC often face challenges due to resistance to chemotherapy and radiation.
Discussion:
- Two recent, large-scale molecular profiling studies of ccRCC have been published.
- These independent analyses yielded remarkably consistent findings regarding recurrent pathway alterations.
Key Insights:
- The studies identified shared molecular pathways that are frequently altered in ccRCC.
- These recurrent alterations are crucial for understanding ccRCC pathogenesis.
Outlook:
- The identified pathway alterations present novel therapeutic targets.
- This research paves the way for developing new treatment strategies for ccRCC.
- Further investigation into these targets may overcome resistance to current therapies.
More Related Videos
Related Concept Videos
Imaging Studies I: Kidney, Ureter, and Bladder Studies
Imaging Studies VII: Vascular Imaging
Imaging Studies III: Computed Tomography

